Related Experiment Videos
Thyrotoxicosis presenting as hypogonadism: a case of central hyperthyroidism
R Dale Childress1, M Nauman Qureshi, Meri Kasparova
1University of Tennessee Health Science Center, Division of Endocrinology and Metabolism, Department of Medicine and the Veterans Administration Medical Center (VAMC) Memphis, TN 38104, USA.
The American Journal of the Medical Sciences
|November 17, 2004
Summary
This study details a rare case of central thyrotoxicosis caused by a TSH-secreting pituitary tumor. The patient was successfully treated with octreotide, managing hyperthyroidism and reducing tumor size.
Area of Science:
- Endocrinology
- Oncology
- Pituitary Disorders
Background:
- Thyroid-stimulating hormone (TSH)-secreting pituitary tumors are a rare cause of hyperthyroidism.
- Diagnosis is aided by third-generation TSH assays, distinguishing from other conditions causing elevated TSH and thyroid hormones.
Observation:
- A patient presented with central thyrotoxicosis, exhibiting a high alpha-subunit-to-TSH molar ratio, absent TSH response to TRH stimulation, and a pituitary mass.
- Hypogonadism preceded thyrotoxicosis symptoms, an unusual presentation for TSH-producing adenomas.
Findings:
- The case highlights diagnostic challenges in differentiating TSH-secreting adenomas from conditions like resistance to thyroid hormone (RTH) and assay interference.
- The patient showed positive response to octreotide therapy, achieving thyrotoxicosis control and significant tumor shrinkage.
Implications:
- This case underscores the importance of comprehensive evaluation for TSH-secreting pituitary tumors in patients with unexplained hyperthyroidism.
- Modern therapeutic approaches, including somatostatin analogs like octreotide, offer effective management for this rare condition.